Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
61-75 of 410
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP
Laura Alder, MD
Christine Bestvina, MD
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®Emerging Therapeutic Strategies in Metastatic NSCLC
Brian P. McDonough, MD, FAAFP
Urs Weber, MD
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS
Adam Brufsky, MD, PhD
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Project Oncology®Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Charles Turck, PharmD, BCPS, BCCCP
Daniel Geynisman, MD
Jonathan Henderson, MD
Addressing Barriers to CAR T Referral in R/R LBCL
Project Oncology®Addressing Barriers to CAR T Referral in R/R LBCL
Steve Jackson, PharmD
Matthew J. Matasar, MD
Tycel Phillips, MD
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Steve Jackson, PharmD
Raghava Reddy Induru, MD
- advertisement
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®Optimizing Multidisciplinary Care in Perioperative NSCLC
Steve Jackson, PharmD
David Tom Cooke, MD, FACS
Joshua Reuss, MD
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Brian P. McDonough, MD, FAAFP
Bilal Siddiqui, MD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Neil M. Iyengar, MD
Sarah H. Donahue, MPH, NP
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP
Petros Grivas, MD, PhD
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Brian P. McDonough, MD, FAAFP
Madison Conces, MD
Midhun Malla, MD
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP
Alicia Lieberman, MD, MS
- advertisement
Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Project Oncology®Getting Biomarker Testing Right in Non-Small Cell Lung Cancer Care
Raghava Reddy Induru, MD
Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Project Oncology®Choosing the Right Treatment in ALK and ROS1-Positive NSCLC
Raghava Reddy Induru, MD
Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Project Oncology®Beyond the Colonoscopy: New Screening Guidelines for Colorectal Cancer
Matt Birnholz, MD
